Search results
Should You Buy This Stock After a Regulatory Setback?
Motley Fool via Yahoo Finance· 6 hours agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 2 hours agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Moderna Has Big AI News. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoModerna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...
Moderna and this solar name are among the most overbought stocks after a record-setting week
CNBC· 2 days agoIt may be time for investors to trim positions in overbought names after the stock market reached...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 4 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Moderna’s long Covid plan
Politico· 3 days agoModerna is eyeing a new target: long Covid. The pharmaceutical company that became a household name when it developed a Covid-19 vaccine now wants to...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 3 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...